The Annual General Meeting of Shareholders (AGM), held on 28 March 2013, adopted the 2012 financial statements and determined the dividend due to holders of ordinary shares for the 2012 financial year at EUR 2.05 per share. After deduction of the interim dividend of EUR 0.60, which was paid out in August 2012, the final dividend amounts to EUR 1.45 per ordinary share. The final dividend can be paid out either in cash, after deduction of 15% dividend withholding tax, or in ordinary shares, which will be charged to the share premium reserve, not subject to dividend withholding tax. The ex-dividend date is 3 April 2013.
The proposal to split the Nutreco share into two has been approved by shareholders. Each ordinary share with a nominal value of EUR 0.24 will be split into two shares with a nominal value of EUR 0.12. The deed of amendment will be effected on Monday 29 April 2013, after close of trading at NYSE Euronext Amsterdam. In this respect, for every ordinary share Nutreco with nominal value EUR 0.24 (ISIN NL0000375400) two new ordinary shares Nutreco with a nominal value of EUR 0.12 will be obtained. Holders of ordinary Nutreco shares, which are in custody with a bank or broker, do not have to take any action themselves. NYSE Euronext Amsterdam has been requested to determine that the listing of the shares Nutreco with the nominal value of EUR 0.12 in the new ISIN code NL0010395208 will start on Thursday 2 May 2013. The Euronext symbol will remain unchanged (NUO).
A number of reappointments were made to the Executive and Supervisory Boards:
Knut Nesse (1967), Chief Executive Officer and Jerry Vergeer (1963), Chief Operating Officer Animal Nutrition have been reappointed as members of the Executive Board for a second period of 4 years.
Rob Frohn (1960) and Ajai Puri (1953) have been reappointed as members of the Supervisory Board for a second period of 4 years. Jaap Vink (1947) has been reappointed as a member of the Supervisory Board for a third period of 4 years.
Furthermore the AGM adopted the following resolutions:
· To release from liability the members of the Executive Board and the Supervisory Board for their management respectively their supervision;
· The appointment of KPMG Accountants N.V. as auditor for the 2014 financial statements;
· To amend the Company's Articles of Association, relating to the one for two share split;
· To extend for a period of 18 months the designation of the Executive Board as the corporate body authorised to issue ordinary shares and to grant rights to subscribe for ordinary shares. The authorisation will be limited to 10% of the issued ordinary shares as at the time of this authorisation, which percentage will be increased to 20% in case of mergers, acquisitions and strategic partnerships;
· To designate for a period of 18 months the Executive Board as the corporate body authorised to restrict or to exclude pre-emption rights entitled to the Shareholders in connection with the issuance of or grant of rights to subscribe for ordinary shares;
· To authorise for a period of 18 months the Executive Board to buy back the
Company's own ordinary shares, other than without financial consideration, representing maximum of 10% of the Company's issued share capital.
On 18 April 2013 Nutreco will present its trading update for the first quarter of 2013.
END PRESS RELEASE
Nutreco
Nutreco is a global leader in animal nutrition and fish feed. Our advanced feed solutions are at the origin of food for millions of consumers worldwide. Quality, innovation and sustainability are guiding principles, embedded in the Nutreco culture from research and raw material procurement to products and services for agriculture and aquaculture. Experience across 100 years brings Nutreco a rich heritage of knowledge and experience for building its future. Nutreco employs approximately 10,000 people in 30 countries, with sales in 80 countries. Nutreco is listed on the NYSE Euronext stock exchange in Amsterdam and reported annual revenues of EUR 5.2 billion in 2012.
www.nutreco.com (http://www.nutreco.com)
For more information:
Jurgen Pullens, Director Investor Relations
Telephone: +31 33 422 6134
Mobile: +31 6 51 599 483
E-mail: jurgen.pullens@nutreco.com (mailto:jurgen.pullens@nutreco.com)
The full press release is attached in the pdf below
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Nutreco via Thomson Reuters ONE
